Bronchitol to be Reimbursed in Australia

14th Mar 12

Release Date: 14/03/2012 12:00am

Pharmaceutical company Pharmaxis is pleased to announce that its cystic fibrosis treatment Bronchitol has been recommended for listing on the Pharmaceutical Benefits Scheme (PBS) in Australia by the government’s expert advisory body the Pharmaceutical Benefits Advisory Committee (PBAC).  


Read full media release - pdf

Categories: News and Media